semi-automatic gradient-based segmentation algorithm (MIMVista corp)
90
Structured Review
MIMVista corp
semi-automatic gradient-based segmentation algorithm
Semi Automatic Gradient Based Segmentation Algorithm, supplied by MIMVista corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/semi-automatic+gradient-based+segmentation+algorithm/semi+automatic+gradient+based+segmentation+algorithm/pm35382980-35-1-5
Average 90 stars, based on 1 article reviews
Semi Automatic Gradient Based Segmentation Algorithm, supplied by MIMVista corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/semi-automatic+gradient-based+segmentation+algorithm/semi+automatic+gradient+based+segmentation+algorithm/pm35382980-35-1-5
Average 90 stars, based on 1 article reviews
semi-automatic gradient-based segmentation algorithm - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Disease Burden on PET Predicts Outcomes for Advanced NSCLC Patients Treated with First-Line Immunotherapy. Article Snippet: First-line immunotherapy (IMT) is now recommended for most patients with advanced non-small cell lung cancer (NSCLC).. We reviewed our institution’s experience with first-line IMT for NSCLC to examine the prognostic value of measures of disease burden on staging FDG-PET/CT.. We found that patients with oligometastatic disease ( ≤3 extrathoracic lesions) and low disease volume had favorable overall survival. |